RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
RxSight (NASDAQ: RXST) announced that its management will participate in the Wells Fargo Healthcare Conference in Boston, Massachusetts, on Wednesday, September 9, 2026, at 9:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight (NASDAQ: RXST) announced that its management will participate in the Wells Fargo Healthcare Conference in Boston, Massachusetts, on Wednesday, September 9, 2026, at 9:30 a.m. ET. A live and archived webcast of the presentation will be accessible via the company’s investor relations website.
Details
News Market Reaction – RXST
On Aug 27, the first trading day after this news, RXST closed 3.61% above the previous close. Our momentum scanner recorded 8 alerts for this stock that day.
Data tracked by StockTitan Argus for the Aug 27 session.
Key Figures
- Conference date
- September 9, 2026
- Wells Fargo Healthcare Conference
- Presentation time
- 9:30 a.m. ET
- Wells Fargo Healthcare Conference
Historical Context
-
Product sales declined and 2026 guidance was withdrawn amid the leadership transition.
-
CEO inducement options and RSUs were granted under Nasdaq rules.
-
Mottiwala became CEO while Kurtz continued as chief medical officer.
-
Mixed results included lower sales guidance and higher gross-margin guidance.
-
Agreement included a $60 million upfront payment, milestones, and royalties.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. ET in Boston, Massachusetts. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.